Published in Curr Opin Lipidol on February 01, 2014
Epigenetic effects of human breast milk. Nutrients (2014) 0.96
Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies. J Nutr Sci (2015) 0.83
Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study. J Pediatr (2016) 0.79
Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic rats. Nutr Metab (Lond) (2016) 0.77
miR-149 controls non-alcoholic fatty liver by targeting FGF-21. J Cell Mol Med (2016) 0.77
Fructose Malabsorption in Systemic Sclerosis. Medicine (Baltimore) (2015) 0.75
Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol. BMC Gastroenterol (2015) 0.75
Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature (2012) 6.37
Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology (2009) 4.16
Consumption of added sugars is decreasing in the United States. Am J Clin Nutr (2011) 3.91
Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology (2010) 3.73
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology (2009) 3.67
Dietary intervention impact on gut microbial gene richness. Nature (2013) 3.56
Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates. Am J Clin Nutr (2013) 3.28
Dietary fructose consumption among US children and adults: the Third National Health and Nutrition Examination Survey. Medscape J Med (2008) 2.65
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol (2013) 2.41
Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun (2013) 2.29
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 2.20
Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol (2008) 2.16
Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology (2013) 1.84
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr (2012) 1.80
Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology (2014) 1.41
Dietary fructose in nonalcoholic fatty liver disease. Hepatology (2013) 1.39
Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol (2012) 1.23
The role of fructose transporters in diseases linked to excessive fructose intake. J Physiol (2012) 1.21
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol (2012) 1.17
Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice. J Nutr Biochem (2010) 1.17
A multidisciplinary clinical program is effective in stabilizing BMI and reducing transaminase levels in pediatric patients with NAFLD. J Pediatr Gastroenterol Nutr (2013) 1.15
Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect (2013) 1.15
No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology (2013) 1.14
Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab (2012) 1.01
Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. J Nutr Biochem (2012) 0.97
Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. BMC Pediatr (2013) 0.97
Monounsaturated fatty acids and atherosclerosis: opposing views from epidemiology and experimental animal models. Curr Atheroscler Rep (2007) 0.95
Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease. Clin Nutr (2013) 0.93
Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study. Arch Pediatr Adolesc Med (2009) 0.93
Prebiotic approach alleviates hepatic steatosis: implication of fatty acid oxidative and cholesterol synthesis pathways. Mol Nutr Food Res (2012) 0.91
Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver disease. Appetite (2012) 0.90
Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (NAFLD). Hepat Mon (2013) 0.90
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. Therap Adv Gastroenterol (2013) 0.88
High rates of fructose malabsorption are associated with reduced liver fat in obese African Americans. J Am Coll Nutr (2012) 0.85
The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). JPEN J Parenter Enteral Nutr (2013) 0.85
Dietary fish oil regulates gene expression of cholesterol and bile acid transporters in mice. Hepatol Res (2012) 0.82
Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. Nutr Metab Cardiovasc Dis (2012) 0.79
Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr (2013) 0.79